Innovation is accelerating progress in early phase drug development. ICON’s Accelerated Pharmaceutical Solutions bring together advanced formulation design, real-time dose flexibility, and world-class CMC expertise to si...
Press releases
-
ICON launches new patient engagement platform to support improved patient experience & enrolment in clinical trials
Increasing visibility of potential study participants to sites and sponsors.
-
Forbes names ICON one of the best employers in America
ICON ranked top CRO in anonymous survey of 50,000 employees across 38 sectors
-
ICON wins multiple categories in 2019 CRO Leadership Awards
ICON recognised for specialised services offering across product development lifecycle -
ICON acquires MolecularMD
ICON enhances it molecular diagnostic testing services, a key area in oncology research, with it's acquisition of MolecularMD.
-
ICON launches new drug safety reporting solution ensuring compliance through automation
Developed on platform deploying rule-based automation for timely delivery of drug safety information.
-
-
ICON wins Pharma Contract Services Company of the Year at the Pharma Industry Awards 2018
The Pharma Industry Awards recognise and celebrate innovative individuals and companies that demonstrate excellence in the Irish Pharma sector -
ICON enhances Endpoint Adjudication Services
Agreement to use Judi, a comprehensive electronic endpoint adjudication system to manage workflow and ensure data quality
-
ICON launches FIRECREST Financial Disclosure
The solution enables secure, centralised, electronic distribution and response capture of Financial Disclosure information.
-
ICON named by Forbes as one of the best employers in America
Forbes ranking of top employers drawn from a survey of 30,000 US employees in 25 industry sectors
